ArticleFrontiers in public health2026
Analysis of epidemiological characteristics and influencing factors of Long COVID syndrome among university students in the post-pandemic era.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze the epidemiological characteristics of Long COVID syndrome in university students during the post-pandemic era, providing evidence for developing prevention strategies and rehabilitation plans for COVID-19 patients. Methods: A cohort study was conducted in November 2023, recruiting students from a university in Nanjing for baseline investigations. Demographic characteristics, vaccination history, infection history, and venous blood samples were collected to detect SARS-CoV-2 IgG and IgM antibody levels. For individuals with prior COVID-19 infections, Long COVID syndrome status was assessed 1 year post-infection. Multivariate logistic regression analysis was employed to identify influencing factors. Results: The study included 246 participants (mean age: 21.88 ± 2.06 years; 65.04% female). Median SARS-CoV-2 IgG and IgM levels were 16.500 (105.000, 239.000) AU/ml and 0.095 (0.053, 0.183) AU/ml, respectively. Among 246 participants with prior COVID-19 infection, 82 (33.33%) developed Long COVID syndrome, with alopecia (36.59%), memory decline (28.05%), and sleep disturbances (28.05%) being the most prevalent symptoms. Multivariate analysis revealed that, compared to the non-Long COVID group, depressive symptoms may be positively associated with Long COVID syndrome (adjusted Conclusion: The incidence of Long COVID syndrome among university students is comparable to that of the general population. A bidirectional relationship may exist between depressive symptoms and Long COVID syndrome, warranting increased clinical and public health attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.